Currently, bacterial conjunctivitis is treated by frequent administration of antibiotic eye drop solutions, which is tedious and patient noncompliant. Contact lenses could be ideal medical devices to sustain the release of ophthalmic drugs, but the incorporation of the latter can alter the optical and physical properties of the lenses. In addition, many contact lens users have reported the pink eye syndrome, making them unsuitable as ocular medical devices. In the present study, we have designed a novel type of lenses containing semi-circular rings loaded with moxifloxacin HCl (a broad spectrum antibiotic) and hyaluronic acid (a comfort agent), respectively, in order to treat bacterial conjunctivitis without altering the critical lens properties. The drug loaded rings were implanted separately within the periphery of the contact lenses using the modified cast moulding technology. The atomic force microscopy report showed an average roughness of 22.27 nm for the implant lens, which was significantly lower in comparison to the marketed Freshlook® (116.27 nm) contact lens. The major amount of moxifloxacin HCl was leached (68.16-74.55%) during the monomer extraction and wet sterilization (autoclave) steps; hence the lenses were terminally sterilized by radiation and packaged under dry condition (dehydrated). The in vitro release data showed release for moxifloxacin HCl and hyaluronic acid up to 96 h. The in vivo drug release studies showed significant improvement [ > MIC for Staphylococcus aureus] in the drug residence time in comparison to the eye drop therapy. The in vivo efficacy study in the staphylococcus aureus induced conjunctivitis showed equivalent healing effect with the single implant contact lens in comparison to the frequent high dose eye drop therapy. The study demonstrated the successful application of the implantation technology to codeliver moxifloxacin HCl and hyaluronic acid from the contact lenses for the extended period of time to treat conjunctivitis.
Introduction
Conjunctivitis is a common cause of the red eye which affects > 6 million people in United States with all ages and socioeconomic classes (Shields and Sloane, 1990; Smith and Waycaster, 2009 ). The disease is characterized by the dilatation of the conjunctival vessels which results in the hyperemia, chemosis, lid edema and the typical eye discharge (Azari and Barney, 2013) . The disease is treated with high and frequent dose of the antibiotic eye drop solution (Sheikh and Hurwitz, 2001 ). The eye drop therapy is very inefficient, due to very low drug residence time in the tear fluid, which leads to poor ocular bioavailability (Tangri and Khurana, 2011) . The limited duration of action of the eye drop requires frequent dosing which affect the patient routine life style (Cronau et al., 2010) . Therefore, a novel approach that improves the drug residence time on the ocular tissue is needed to overcome the limitations of the eye drop therapy.
The use of the therapeutic soft contact lenses could be a promising approach to increase the drug residence time on the cornea to treat the conjunctivitis Huang et al., 2016; Busin and Spitznas, 1988) . In the last few decades, scientists have succeeded to control the delivery of the drugs through the contact lenses using several approaches like the soaking method, molecular imprinting, drugnanoparticles, drug-film, ion-ligand systems, supercritical fluid technology, etc. (Furqan et al., 2009; Ranch et al., 2017; Hsu et al., 2014; Carvalho et al., 2015; Xinming et al., 2008) . soaked the conventional and silicon contact lenses in the moxifloxacin solution for 24 h, and observed the sustained drug release up to 24 h . Jones and Hui (2013) loaded ciprofloxacin and dexamethasone in the contact lenses by soaking method using acetate buffer with cyclodextrins and found high burst release (Jones and Hui, 2013) . Bajgrowicz et al. (2015) loaded ciprofloxacin and moxifloxacin in the daily disposable contact lenses and found the high burst release reaching a plateau state within 15 min (Bajgrowicz et al., 2015) , similar results were also observed by for the fluconazole . The high initial burst release with steep decline in the drug release profile of the contact lenses prepared using soaking method make this technique unsuitable for drug loading.
To treat the allergic conjunctivitis, González-Chomón et al. (2016) developed the biomimetic contact lenses using acrylic acid, 2-acrylamido-2-methyl-1-propane-sulfonic acid and benzyl-methacrylate as functional monomers. The lenses showed sustained release up to 24 h, inhibiting the response of the sensitized mast cells (González-Chomón et al., 2016) . Negin (Malakooti et al., 2015) incorporated the functional monomers and applied the molecular imprinting technology to load polymyxin B and vancomycin (Malakooti et al., 2015) . However, the high degree of cross linking in the molecular imprinting can alter the optical and physical characteristics of the contact lenses. Paradiso et al. (2016) incorporated vitamin E as a diffusional barrier to extend the release of levofloxacin and chlorhexidine from the 1-DAY ACUVUE® and ACUVUE OASYS® contact lenses (Paradiso et al., 2016) . The significant reduction in the water content of the silicone contact lenses was observed by incorporating vitamin E in an attempt to extend the release of ciprofloxacin and betamethasone (Rad and Mohajeri, 2017; Rad and Mohajeri, 2016) . Guzman et al. (2017) developed the multi-layer contact lenses with drug layer sandwiched between vitamin E as the barrier layers. The Quasi-Case II non-Fickian controlled diffusion release was achieved for 30 h, with no burst release (Guzman et al., 2017) . Qin et al. (2017) developed the contact lenses loaded with the fluorous-tagged ciprofloxacin which shows the excellent antimicrobial activity against the pseudomonas aeruginosa (Qin et al., 2017) . While these approaches have demonstrated the contact lenses as an ideal medical device to control the release of ophthalmic drugs in the treatment of conjunctivitis, but the method of incorporation of drug/formulation have altered the optical and physical properties of the contact lenses Gulsen and Chauhan, 2004; Guzman-Aranguez et al., 2013) . Also, many contact lens users have reported the pink eye syndrome at the end of the day making it unsuitable to be accepted as the medical device (Chynn et al., 1995; Schein et al., 1989) .
In the present study, we have designed a novel moxifloxacin HCl and hyaluronic acid (HA) loaded semi-circular acrylate rings which were implanted separately within the periphery of the hydrogel contact lenses using the modified cast moulding technology (Desai et al., 2018) . The objective was to treat the conjunctivitis and to provide the comfort to the patient's eye with the dual delivery of antibiotic (moxifloxacin HCl) and comfort enhancing agent (HA) from the single implant contact lens. Thus the implant contact lenses could improve the patient adherence to the therapy and thus can lead to better clinical outcomes for the treatment of conjunctivitis.
Materials and methods

Materials
Hydroxylethylmethacrylate (HEMA), methacrylic acid (MAA), Irgacure® (1-Hydroxycyclohexyl phenyl ketone), ethylene glycol dimethacrylate (EGDMA), StainAll dye, Tetra butyl ammonium hydrogen sulfate and Triethylamine were purchased from Sigma-Aldrich Chemicals (St. Louis, MO, USA). Hyaluronic acid was purchased from Shandong Runxin Biotechnology Co., Ltd (China). Ultrapure water (18.2 MΩ cm) was obtained from synergy U.V. Millipore water purification system. All other reagents were purchased from Sigma-Aldrich Chemicals (MO, USA).
Formulation development
Fabrication of the drug-loaded semi-circular rings/implants
The antibiotic-loaded implants were fabricated at three different concentration of the moxifloxacin HCl, as shown in the Table 1 . The 40 µm thickness implants were prepared by the free radical polymerization technique using the monomer mixtures. The composition of the monomer mixture for the base contact lens and the drug-loaded implants are shown in the Table 1 .
The required quantity of the moxifloxacin HCl was added in the mixture of water and Tween 20, followed by the addition of other ingredients like HEMA, MAA, EGDMA and Irgacure D. The drug-laden monomer mixture was sonicated for 15 min to remove the air bubbles. The mixture was then poured into the glass moulds which were separated by Teflon spacer of 40 μm. The mould was then shifted to the Ultraviolet transilluminiator cabinet and the sheet was polymerized at 360-370 nm for 45 min. The drug-laden sheet was then punched using the metal borer to get a circular ring with 6 mm inner diameter and 8 mm outer diameter. The circular ring was further carefully cut into the two equal parts from the center using the cutter to get a semi-circular ring/implant of 2.1 ± 0.3 mg (Fig. 1) . Similarly, the HA-laden semi-circular rings/implants of 2.1 ± 0.2 mg was fabricated using the free radical polymerization technique, with the curing time of 30 min . The semi-circular rings were stored in the desiccators (45% relative humidity) at room temperature till further use.
Implantation of the drug-loaded semi-circular rings/implants in the contact lenses
The dual implant contact lens (14.2 mm outer diameter and 6.5 mm base curve) was fabricated by the modified cast moulding method. As shown in Fig. 1 , moxifloxacin HCl-implant and HA-implant was placed in the female mould (polypropylene mould) keeping a distance of 6 mm from the center, followed by the addition of the excess amount of the monomer mixture (base contact lens monomer solution, Table 1 ). The male and female moulds were aligned and they were cured by exposing to UV transilluminiator at 360-370 nm for 1 h. The dual implant contact lenses were removed and preserved at the room temperature in the desiccator (45% relative humidity). The optical transparency of the implant contact lens was not altered as the semi-circular rings/implants were placed towards the outer periphery of the contact lens leaving a region of 6 mm diameter from the center for clear vision. The implant contact lenses were coded as MOX-HA-I-50-CL, MOX-HA-I-100-CL and MOX-HA-I-150-CL for the respectively implants as shown in Table 1 .
Moxifloxacin HCl and HA-laden contact lenses prepared by soaking method
The experiment was performed to compare the semi-circular rings implant contact lenses with the soaked contact lenses. Moxifloxacin HCl and HA was loaded into the contact lenses (fabricated using base contact lens monomer mixture and processed to remove unreacted monomer according to Section 2.3.4) by soaking in the simulated tear fluid (STF, pH 7.4, osmolarity = 295.7 mosmoles/L, 2 ml, prepared by dissolving 0.9% w/v sodium chloride, and 0.015% w/v sodium bicarbonate in de-ionized water) containing a fixed strength of 0.15% w/ v HA and varying the concentration of the moxifloxacin HCl (1 mg/ml, 3 mg/ml, and 5 mg/ml coded as MOX-HA-SM-1, MOX-HA-SM-3, and MOX-HA-SM-5 respectively). The contact lenses were then autoclaved (121°C, 15 psi for 30 min) and thereafter soaked for a period of 48 h in solutions of different concentration as reported above. After soaking, the contact lenses were removed and carefully blotted to remove the excess of the soaking solution from the surface of the contact lenses and were then subjected for characterization (Kim and Chauhan, 2008) . The soaking solutions were analyzed to calculate the uptake of moxifloxacin HCl and HA by a developed and validated HPLC method at 293 nm (Respaud and Grayo, 2012) and by the colorimetry method (using StainAll dye) at 640 nm (Fagnola et al., 2009; Homer et al., 1993) respectively.
Terminal sterilization
Mostly the contact lenses sterilized by the autoclaving method (wet process) have very high chances of the drug leaching, especially with the water soluble drugs like moxifloxacin HCl. The implant contact lenses [MOX-HA-I-50-CL, MOX-HA-I-100-CL and MOX-HA-I-150-CL] were sterilized using autoclave (121°C, 15 psi and 30 min) in 2 ml of the STF. After sterilization, the STF was analyzed for the moxifloxacin HCl and HA content to calculate the percentage leaching of the drugs from the implant contact lenses . All readings were recorded in triplicate.
In another set, the implant contact lenses were sterilized by UV radiation sterilization technique using the UV-B lamp (G6T5E, Sankyo Denki Co. Ltd., Japan) at 290-310 nm applying 500 mW/cm 2 for 180 min (Gritz et al., 1990 ).
2.3. Characterization of the hydrogel contact lenses 2.3.1. Swelling study The weight of the dry contact lens (W D ) after removing from the mould and after 24 h of wetting in the simulated tear fluid (W S ) was measured at 37°C (Maulvi et al., 2014; Jung et al., 2013) . The percentage swelling of each batch was then calculated as follows:
The optical transparency of the therapeutic contact lenses should not be affected due to the presence of the drug or the drug loaded formulation. Any alteration in the transparency of the contact lens would directly hinder the vision of the contact lens user. The optical transparency of the soaked and implanted contact lenses was determined by UV-vis spectrophotometer. The contact lenses were hydrated by soaking it in the simulated tear fluid for an overnight. This hydrated contact lens was carefully cut in to a small 0.5 × 0.5 cm area and mounted in the glass cuvette. The cuvette was placed in the UV-vis spectrophotometer and the transmittance was measured at 630 nm wavelength. All readings were recorded in triplicate.
Quantification of the drug loaded in the contact lenses
The soaked contact lenses and the MOX-implants were separately transferred in the screw capped glass vials containing 25 ml of 10%v/v aqueous methanolic solution. The vials were agitated at 100 rpm in the incubator shaker for 10 days at 37°C to extract the moxifloxacin HCl. After 10 days, the solutions were analyzed for the moxifloxacin HCl using HPLC at 293 nm after appropriate dilution. Similarly, to quantify HA the soaked contact lens and HA-implants were separately transferred in the glass vial containing 25 ml of distilled water. The HA was quantified by the developed and validated colorimetric method (Fagnola et al., 2009; Homer et al., 1993) using Stain-All dye after suitable dilution at 640 nm. All readings were recorded in triplicate.
Removal of unreacted monomers from the implant contact lenses
To remove the un-reacted monomers left after the curing process, the implant contact lenses were individually placed in the 5 ml of boiling water for 15 min (Alvarez Lorenzo et al., 2002; Andrade Vivero et al., 2007) . The amount of moxifloxacin HCl and HA leached out in the water was quantified by the HPLC and colorimetric method respectively. All readings were recorded in triplicate.
Atomic force microscopy (AFM)
AFM is a very powerful tool to analyze the surface topography and to compare the hydrated surface of the contact lenses on the numerical basis (Guryca et al., 2007) . The method avoids the artefacts due to the dehydration which can occur with low voltage scanning electron microscopy (SEM). The marketed contact lens (Freshlook One Day Color Contact Lens by Alcon) and the implant contact lens [batch MOX-HA-I-150-CL] were evaluated for the surface morphology. The 25 µm × 25 µm area was analyzed at three different locations in the surface tapping mode and the average surface roughness was calculated by the inbuilt software in Atomic Force Microscope (AFM) -NT-MDT (Model No: NT MDT NTEGRA Prima, USA). The implant area was analyzed in case of the implant contact lens. The AFM consists of a micro scale cantilever with a sharp tip (probe) that is used to scan the specimen surface. The cantilever is typically made of silicon or silicon nitride with a tip radius of curvature of the order of nanometers. When the tip is brought into the proximity of a sample surface, forces between the tip and the sample cause the cantilever to deflect according to the Hooke law. All images were collected in the height mode, which keeps the force constant (Lira et al., 2008; Giraldez et al., 2010) . 
In vitro release study
The in vitro release study of the soaked contact lenses, implant contact lenses (wet sterilized and radiation sterilized) and the semicircular implants (individually without autoclave) were carried out by immersing them separately in 2 ml of STF at 34°C with constant stirring in the incubator shaker at 100 RPM Ciolino et al., 2009) . The 2 ml of STF was then completely decanted and superseded by the fresh STF at the pre-established time intervals to mimic the in vivo sink condition. The amount of the moxifloxacin HCl and HA released was quantified using HPLC at 293 nm and UV spectrophotometer at 640 nm (colorimetric method) respectively. The sampling was carried out until there was no increase in the drug concentration in 2 successive measurements. The studies were carried out six times (n = 6).
Animal studies
All animal studies were performed with prior approval from the Institutional Animal Ethical Committee (IAEC) (Protocol No: MPC/ IAEC/11/2017) of Maliba Pharmacy College, Bardoli, India. The in vivo studies were designed according to the guidelines of the CPCSEA (Committee for the Purpose of Control and Supervision of Experiment on Animals). New Zealand white rabbits of either sex weighing between 3.8 and 4.2 kg were housed individually in stainless steel cages in a light controlled room at 20 ± 1°C with no restriction of food and water intake.
In-vivo drug release study
The in-vivo drug release study was conducted to assess the amount of moxifloxacin HCl released from the implant contact lenses (MOX-HA-I-150-CL, 148 µg loading of MOX) in the rabbit tear fluid in comparison to 0.5 %w/v moxifloxacin HCl eye drop therapy (1 drop = 250 µg moxifloxacin HCl) Chhonker et al., 2015) . The radiation sterilized moxifloxacin HCl implant contact lenses were gently placed on the rabbit cornea (right eye) without anaesthesia with utmost care (n = 6 rabbits, left eye control). At the specified time intervals, 60 μl of the saline solution (0.9% NaCl) was instilled in the lower conjunctival sac of the right eye and after 5 s maximum tear fluid was collected using micropipette (10-100 µl capacity) in a pre-weighed eppendorf tube. The collected tear fluids were treated with 1 ml of methanol to precipitate out the biological proteins, followed by the centrifugation for 15 min (freeze centrifuge, 10,000 RPM). The supernatant was collected and analyzed for the moxifloxacin HCl content using LC-MS (TSQ Quantum Access, Thermo Scientific, USA). The measured moxifloxacin HCl concentration in the tear fluid was plotted against time and compared with the single topical moxifloxacin HCl eye drop instillation (0.5% w/v MOXIZEE).
Efficacy study
The efficacy of the implant contact lenses were evaluated using the New Zealand white rabbits, and was compared with the conventional eye drop therapy. The conjunctivitis was induced using young culture of the Staphylococcus aureus (ATCC 25923, 100 CFU/ml) (Ilechie et al., 2012) . Rabbits' eyes were examined using portable slit lamp prior to the induction of the conjunctivitis to exclude any abnormalities. The study includes 4 groups (n = 6 rabbits in each group) and both the eyes of rabbits were utilized for the study.
• Group 1: Uninfected and untreated (i.e. conjunctivitis was not induced)
• Group 2: Conjunctivitis was induced and treated with sterile saline (0.9%w/v NaCl) solution (Negative control).
• Group 3: Conjunctivitis was induced and treated with commercial eye drop solution containing (0.5% w/v, MOXIZEE) moxifloxacin HCl (Positive control).
• Group 4: Conjunctivitis was induced and treated with implant contact lenses (MOX-HA-I-150-CL, 148 µg loading of MOX, Test group).
In this study, the group 1 rabbits were caged and neither the conjunctivitis was induced nor they were treated with any of the formulation; while the conjunctivitis was induced in both the eyes of group 2-4 using the young culture of the Staphylococcus aureus. The 50 µl of culture solution (10 2 CFU in 10 µl of tryptic soy broth (O'Callaghan, 2018) was gently instilled in the lower conjunctival sac of the rabbit eye and holded for few seconds to ensure the uniform spearing of the bacteria. After 48 h, the rabbits' eyes showed the symptoms of discharge, chemosis, conjunctival congestion and palpebral fissure, indicating the successful induction of the conjunctivitis. The treatment was started from the day 3, i.e. after successful induction of conjunctivitis. In group 2, the rabbit's eyes were treated with one drop of the sterile saline solution every 4 h, which served as the negative control group. In the group 3 (positive control group), rabbit's eyes were treated with one drop of the moxifloxacin HCl eye drop solution (0.5% w/v) in 4 h interval. The radiation sterilized implant contact lenses (MOX-HA-I-150-CL, 148 µg loading of MOX) were carefully placed on the cornea of the group 4 (test group) without anaesthesia. The rabbits were kept under observation and symptoms like the discharge, chemosis, conjunctival congestion and palpebral fissure were observed and scored at every 12 h (Table 2 ) (Wahaab et al., 2015) . The treatment was conducted for 4 days after the induction of the conjunctivitis.
Statistical analysis
Statistical analysis was carried out using the SPSS 21.0 for Windows. The t-test (2 tailed) and one-way analysis of variance (ANOVA) was used to compare the different groups, after confirming the normality and homogeneity of variance.
Results and discussion
3.1. Characterization of the contact lenses 3.1.1. Swelling study
The percentage swelling (water content) is one of the critical parameter that decides the wearable fate of the contact lens and the swelling capacity majorly depend upon the materials (monomers) from International Journal of Pharmaceutics 548 (2018) 139-150 which they have been fabricated. In the present work, we have used the p-HEMA based monomers for fabricating the contact lenses and the implants, which have acceptable water retention capability for the comfort wear. The soaked contact lenses showed an insignificant (p > 0.01) changes/alterations in % swelling in comparison to the control contact lenses (Table 3 ). The results indicate that the presence of the hydrophilic drugs (moxifloxacin HCl and HA) did not alter the swelling behavior of the contact lenses. The moxifloxacin HCl loaded implants showed significant decline (p < 0.01) in the swelling behavior, which is generally not preferred as it can change the shape of the contact lens (Pinchuk et al., 1984) . Although significant distortion in the shapes of the final fabricated contact lenses were not observed. The HA-loaded implants did not show any significant change (p > 0.05) in the % swelling in comparison to the control contact lenses. The final implant contact lenses did show reduction in % swelling, which suggests the tailoring of the monomer composition of implants in future clinical studies.
Optical transparency
The % transmittance value should be greater than 95% for the contact lens to provide an unhindered clear vision to the users. The blank contact lenses when soaked in the different concentrations of the moxifloxacin HCl, the optical transparency of the soaked contact lenses (after 48 h) decreased significantly (p < 0.05) with an increase in the concentration of the moxifloxacin HCl in the soaking solution (Table 3 ). This was due to inherent characteristics of the moxifloxacin HCl which shows yellow color. Thus the soaking method was not preferred for the colored drugs like the moxifloxacin HCl. While the implant contact lenses did not show reduction in the optical transparency, which was expected since the implants/rings were placed towards the outer periphery of the contact lens leaving a region of 6 mm diameter from the center, as shown in Fig. 1 . Hence this technology can be an outbreak for the delivery of coloured compounds via contact lenses.
Quantification of the drug loaded in the contact lenses
The soaked contact lenses and the implants were evaluated for the uniform dispersion of the drugs in the contact lens and the reproducibility of the fabrication process. The drug loaded values for the soaked contact lenses and the implants are shown in the Table 4 . As expected, the results of the soaked contact lenses indicate that as the concentration of the moxifloxacin HCl in the soaking solution increases, proportionally the drug loading also increased. The high standard deviation values suggest poor reproducibility of the soaking method to load the drug. The reasons for the deviations could be the uneven drug precipitation or drug adsorption onto the side of the vial. Also the concentrations of the drug-loading solutions were many folds higher than the amount of drug uptake in the lens, giving rise to error in the measurements.
The uptake of HA from the soaking solution (0.15% w/v HA; common for all three batches) was found to be in the range of 7.48 ± 0.35 to 8.10 ± 0.52 µg. The low uptake values indicate that the HA was adsorbed only on to the surface of the contact lens, with no penetration inside the matrix structure, owing to its high molecular weight .
The drug loaded values of the moxifloxacin HCl and HA implants were in the range of 68.73 ± 9.12 to 148.06 ± 12.30 µg and Table 6 Leaching data of Moxifloxacin HCl and HA during the sterilization step (Mean ± SD, n = 3). 17.92 ± 2.01 to 18.65 ± 1.94 µg respectively. According to the reported literature calculations , moxifloxacin HCl loading in the implant was sufficient to treat the conjunctivitis, however the system should show sustained release for at least 3 days. The low standard deviation values (implants) suggest the reproducibility and reflect the suitability of the implant fabrication process. The results also confirmed no degradation of the drugs during the fabrication process.
Removal of unreacted monomers from implant contact lenses
The implant contact lenses were fabricated by free radical polymerization technique, so it was necessary to remove the un-reacted monomers from the hydrogel matrix. The percentage loss of moxifloxacin HCl and HA during the monomer extraction in 5 ml of boiling water are shown in the Table 5 . The results showed that 26.34 ± 5.555 to 28.77 ± 3.40% of the moxifloxacin HCl and 3.80 ± 0.86 to 4.01 ± 0.84% of the HA were leached out during the monomer extraction step. Moxifloxacin HCl is water soluble drug, thus high leaching was expected. While HA implant showed < 5% of leaching, 
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Effect of terminal sterilization
The contact lenses were sterilized to prevent the eye irritation and infection which may lead to patient non-compliance. The amount of moxifloxacin HCl and HA leached out/lost during the sterilization of the implant contact lenses are shown in Table 6 . Leaching of the moxifloxacin HCl from the implant contact lenses was 41.39 ± 04.20 to 46.81 ± 10.59%, while only 3.26 ± 1.29 to 4.29 ± 1.89% of the HA was lost during the sterilization step. The results are obvious as discussed in the monomer extraction step.
The prevention of drug loss during the wet sterilization process (autoclaving) has been a challenging task for the researchers. In our previous work , we have addressed this critical issue using the pH sensitive Eudragit S100 nanoparticles. This concept worked with only low dose (potent) drugs like cyclosporine, bimatoprost, etc. In case of the moxifloxacin HCl, high dose was required to be loaded in the contact lenses, which would add the huge mass of the International Journal of Pharmaceutics 548 (2018) 139-150 polymeric material affecting the physical properties of the implants and the contact lenses. Therefore, the implant contact lenses were not preferred to be supplied in the hydrated state (i.e. after moist sterilization). Thus, the option of sterilizing the implant contact lenses in dry state using radiation sterilization technique, followed by the packaging under the aseptic condition will overcome the problem of drug loss under the hydrated conditions.
Atomic force microscopy (AFM)
The AFM was used to evaluate the alterations in the surface smoothness of the contact lenses, due to the implantation of the HA and the Moxifloxacin HCl. The AFM report of Freshlook contact lens (marketed by Alcon) and implant contact lens (MOX-HA-I-150 CL) are shown in Fig. 2 . The average roughness of the Freshlook contact lens was found to be 116.07 nm, while the implant contact lens showed comparatively much lower value of 22.27 nm, suggesting the comfort wear for users. In the literature, Vilem Guryca (Guryca et al., 2007) visualized the surface roughness of various market contact lenses, with average surface roughness was in the range of 0.7-18.8 nm. Also, the similar study was conducted by Giraldez et al. (2010) , where the average surface roughness of various marketed contact lenses ranged between 2.34 nm and 12.99 nm.
The presence of the moxifloxacin HCl and the HA implants did not affect the surface smoothness of the contact lenses, instead it was much smoother then the marketed cosmetic contact lens. Thus the contact lenses fabricated by the implantation technology will outweigh the discomfort caused by the conventional contact lens wear which will prompt easy and comfort wear. The cumulative release (µg) and release rate (ng/h) profiles are presented in Figs. 3 and 4 respectively. During the soaking period of 48 h, the uptake of moxifloxacin HCl by the contact lenses were found to be 72 ± 07, 529 ± 24 and 931 ± 75 µg for batch MOX-HA-SM-1, MOX-HA-SM-3 and MOX-HA-SM-5 respectively. The in vitro release data showed the high initial burst release (> 80%) of moxifloxacin HCl, which indicates the release of adsorbed drug from the contact lenses, followed by the rapid decline in the drug release rate. The results suggest the drawback of the soaking method for water soluble drug moxifloxacin HCl. The drug release profiles of the different batches showed increase in the drug release rate with increase in the drug loading amount (MOX-HA-SM-5 > MOX-HA-SM-3 > MOX-HA-SM-1), while the pattern of drug release rate remained the same. The drug was detected in the HPLC till 72 h, 72 h and 96 h for MOX-HA-SM-1, MOX-HA-SM-3 and MOX-HA-SM-5 batches respectively. However the batches MOX-HA-SM-3 and MOX-HA-SM-5 cannot be used for the therapeutic purpose, as the optical transmittance values were lower than 90% (Table 3 ). The cumulative amount of moxifloxacin released from the soaked contact lenses were lower than the uptake values, which indicate that some part of the drug is either permanently entrapped inside the matrix of the contact lens or was not detectable on HPLC. The other reason for the difference could be the error in the measurements of the drug uptake values, as the concentrations of the drug-loading solutions were many folds higher than the amount of drug loaded in the lenses.
Similarly, the high initial burst release of HA was observed from the soaked contact lenses (for all three batches), with the cumulative release of 6.48 ± 0.35 μg (Figs. 5 and 6 ). The results are obvious, because the HA has high molecular weight which restricts its entry into the aqueous channels of the contact lenses and gets adsorbed only on the surface, which released rapidly in flux media .
3.3.2. In vitro release of moxifloxacin HCl and HA from the implant contact lenses after monomer extraction and wet sterilization
The implant contact lenses were treated for the monomer extraction and the wet sterilization steps (autoclave) prior to the in vitro release study. The total amount of the moxifloxacin HCl leached during the above treatment was 48.22 µg (70.15%), 75.35 µg (74.55%) and 100.92 µg (68.16%) for MOX-HA-I-50-CL, MOX-HA-I-100-CL and MOX-HA-I-150-CL batches respectively (Tables 5 and 6 ). The results showed that the major amount of the moxifloxacin HCl was lost during the monomer extraction and the wet sterilization steps. The lenses after treatment were shifted to the in vitro release study where the cumulative moxifloxacin HCl released was found to be 5.12 µg, 16.07 µg and 20.25 µg for MOX-HA-I-50-CL, MOX-HA-I-100-CL and MOX-HA-I-150-CL batches respectively. The cumulative release (µg) and release rate (ng/h) profiles of the implant contact lenses post monomer extraction and sterilization are presented in the Figs. 5 and 6 for HA and Figs. 7 and 8 for moxifloxacin HCl respectively.
The system showed dual phase release pattern, initially there was a burst release (desired in case of antibiotics to kill the microorganism) of the moxifloxacin HCl from the aqueous channels of the contact lens and the implant matrix, followed by the extended release of tightly bound drug from the implant matrix (from 72 h to 96 h), due to the drugpolymer interactions. Thus, even with the low drug loading in comparison to the high drug-loaded soaked contact lenses, the implant moxifloxacin HCl rings showed extended release. The results indicate that the matrix structure of the implant and contact lens restricted the release of the moxifloxacin HCl. It was also observed that as we increased the amount of the moxifloxacin HCl loading in the implants, the release duration was improved. The HPLC spectra of the moxifloxacin HCl released from the implant contact lenses did not show any degradation peaks, which confirmed the chemical integrity of the moxifloxacin HCl.
The HA loading in the implant was uniform in all the three batches. The in vitro release profile of the HA from the implant contact lenses showed significant reduction (p < 0.01) in the burst release and the release rate duration (sustained effect) was improved in comparison to the soaked contact lenses. The sustained release of HA from the HAimplant was due to the high molecular weight and chain like structure of the HA, which resist it to cross the mesh structure of the HA-implant. The mechanism of the HA release from the implant could be highly complex involving relaxation of HA chain in implant matrix followed by dissolution and release in the media.
In vitro release of moxifloxacin HCl from the implant contact lenses after radiation sterilization
The in vitro release was also carried out after the dry sterilization (radiation), as the major part of the moxifloxacin HCl was leached lost during the monomer extraction and the wet sterilization (autoclave) steps. We have performed in vitro flux study of moxifloxacin HCl implant to evaluate the rate controlling factors (resistance barrier, either implant matrix or lens matrix) which may be responsible for restricting the release of moxifloxacin HCl from the implant contact lenses. We have reported in our previous studies , that the sterilization did not cause major loss of the HA and the factors controlling the release of HA from the HA-implant were long chain polymer structure of HA, matrix of implant and contact lens. Thus we have not conducted in vitro studies of the HA implants and the implanted contact lenses (after radiation sterilization). The cumulative release (µg) and the release rate (ng/h) profiles of the moxifloxacin HCl from the implants and implanted contact lenses (radiation sterilization) are presented in Figs. 9 and 10 respectively.
The in vitro release profiles of the radiation sterilized implant contact lenses showed the cumulative moxifloxacin HCl release of 50.99 ± 10.25 µg, 97.57 ± 6.30 µg and 143.41 ± 9.02 µg from MOX-HA-I-50-CL, MOX-HA-I-100-CL and MOX-HA-I-150-CL batches respectively. The data showed the significant improvement in the cumulative release and the release rate profiles of the implant lenses in comparison to the wet sterilized lenses. The release rate at 12 h from the wet sterilized contact lenses were in the range of 54 to 145 ng/h, while the radiation sterilized contact lenses showed significant increase in the values from 556 to 1375 ng/h. After 48 h, the wet sterilized contact lenses showed release rate of 8.9-15.88 ng/h, while the radiation sterilized contact lenses showed 43-191 ng/h. Also, after 96 h, the MOX-I-150-CL batch showed release rate of 10 ng/h. The results clearly suggest the advantage of the packaging and dispensing the implant contact lenses in dry state using radiation sterilization rather than the wet sterilization method. The release rate profiles were improved with increase in the loading of the moxifloxacin HCl in the implants.
The in vitro release profile of the implant (i.e. without implantation) showed 78-90% release of the moxifloxacin HCl within 48 h. The results suggest the significant role of the contact lens matrix along with the implant matrix, as a barrier in extending the release rate of water soluble moxifloxacin HCl. The mechanism of the extended drug delivery, may involve diffusion of the STF in aqueous channels of the Conjunctivitis was induced and treated with the implant contact lenses (Test group). The conjunctivitis was developed (using staphylococcus aureus) on day 2 and the treatment was started on day 3. contact lens matrix, with subsequent penetration of STF in the implant, followed by dissolution and diffusion of the moxifloxacin HCl in the release media.
In-vivo drug release study
The in vivo drug release study (Fig. 11 ) was performed to compare the tear concentrations of the moxifloxacin HCl achieved by the continuous use of the implant contact lenses (MOX-I-150, 148.06 ± 12.30 µg loading) with the conventional therapy of 0.5% w/ v moxifloxacin HCl (MOXIZEE) eye drop (one drop = 250 µg of moxifloxacin HCl). The implant contact lenses were used after hydrating at the room temperature for 24 h using 2 ml of sterile STF, whereby 7.51 µg of moxifloxacin HCl was leached in the STF. The LOD (limit of detection) of the moxifloxacin HCl was 10 ng. The pure moxifloxacin HCl standard (95% w/w purity) and the drug released from the implant contact lenses (24 h reading) showed the substantially similar high resolution mass spectra (Fig. 12) . Thus, the LC-MS results confirmed the integrity of the drug eluted from the implant contact lenses as moxifloxacin HCl.
The maximum concentration (C max ) of 1378.16 ± 643.64 µg/ml was measured in the rabbit tear fluid at 5 min in the eye drop group, followed by the rapid decline. The tear kinetic profile was found to be consistent with the reported studies that too demonstrated rapid decline in the concentrations within 2 h (Westermeyer et al., 2011; Stroman et al., 2005; Callegan et al., 2003; Miller, 2008) . While the implant contact lenses showed an initial burst release (C max ) 560.22 ± 416.89 µg/ml followed by extended release in the tear fluid up to 48 h. The concentration of the moxifloxacin HCl in tear fluid remained above the MIC (4 µg/ml) for Staphylococcus aureus, the most frequent cause of the conjunctivitis in humans. Prolonged retention of the moxifloxacin HCl in the pre-corneal area using the implant contact lenses can substantially decrease the dose and dosing frequency of the moxifloxacin HCl to achieve the desired therapeutic levels in comparison to the eye drop therapy.
Efficacy study
The conjunctivitis was successfully induced in the rabbit eyes after 48 h using the young culture of the Staphylococcus aureus, as confirmed by the symptoms of conjunctival edema of the eyelids, beefy red conjunctiva and the swollen eye lids. No significant difference (p > 0.01) in the conjunctival scores were observed among the group 2, 3 and 4 ( Figs. 13 and 14) . On day 3, the treatment with eye drop and the contact lens was started in the group 3 and 4 respectively. After 24 h of treatment, i.e. on the 4th day, the discharge was reduced in the group 4, while no improvement was observed in the group 2 (saline treated) and the group 3 (eye drop treatment). On the 5th day, the inflammatory symptoms in the group 3 and 4 was significantly reduced (p < 0.01) in comparison to the group 2 (Negative control). On the third day of the treatment, i.e. 6th day, the rabbits' eye in the group 3 and 4 showed no discharge along with the minimal congestion and edema. The eyes were completely cured on the 4th day of the treatment in the group 3 and 4. While the inflammatory symptom still persisted in the group 2. The outcome of the study suggests that, a single low dose (148 µg of moxifloxacin HCl) implant contact lens was as effective as the frequent high dose eye drop therapy.
Conclusion
The study demonstrated the successful application of the implantation technology for the dual delivery of the moxifloxacin HCl and HA to treat the bacterial conjunctivitis without altering the critical lens properties. The AFM report confirmed the smooth surface of the implant contact lenses for the comfort wear. The implant contact lenses showed the major loss (leaching) of moxifloxacin HCl during the monomer extraction and the sterilization step, which was resolved by sterilizing the lenses in the dry state using radiation sterilization technique. The in vivo drug release study showed sustained moxifloxacin HCl release for more than 48 h in the tear fluid, suggesting the improvement in the drug residence time using the implant contact lenses. The in vivo efficacy study in the conjunctivitis induced rabbits' eye showed equivalent healing effect with the single implant contact lens in comparison to the frequent high dose eye drop therapy. From this research work, it was concluded that the concept of the semi-circular rings implanted contact lenses have a strong potential to serve as a good platform for the sustained ophthalmic drugs delivery to treat the conjunctivitis.
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